Cytokines and the endocrine system. II. Roles in substrate metabolism, modulation of thyroidal and pancreatic endocrine cell functions and autoimmune endocrine diseases

European Journal of Endocrinology

Volumn 134, Issue 1, 1996, Pages 21-30

  Mandrup Poulsen, Thomas ^a   Nerup, Jørn ^a   Reimers, Jesper I ^a   Pociot, Flemming ^a   Andersen, Henrik U ^a   Karlsen, Allan ^a   Bjerre, Ulla ^a   Bergholdt, Regine ^a  

^a STENO DIABETES CENTER   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; THYROTROPIN; TUMOR NECROSIS FACTOR;

AUTOIMMUNITY; HUMAN; PANCREAS DISEASE; PRIORITY JOURNAL; REVIEW; THYROID DISEASE;

EID: 0030038893     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1340021     Document Type: Review

References (174)

1. Mandrup-Poulsen T, Nerup J, Reimers JI, Pociot F, Andersen HU, Karlsen AE, et al. Cytokines and the endocrine system. I. The Lmmunoendocrine network. Eur J Endocrinol 1995; 133:660-71
2. Rasmussen ÅK, Feldt-Rasmussen U, Bendtzen K. The effect of interleukin-1 on the thyroid gland. Autoimmunity 1993;16:141-8
3. Weetman AP. Autoimmune thyroiditis: predisposition and pathogenesis. Clin Endocrinol 1992;36:307-23
4. Weetman AP, McGregor AM. Autoimmune thyroid disease: further developments in our understanding. Endocr Rev 1994;15:788-830
5. Charreire J. Immune mechanisms in autoimmune thyroiditis. Adv Immunol 1989;46:263-334
6. Mandrup-Poulsen T, Helqvist D, Molvig J, Wogensen LD, Nerup J. Cytokines as immune effector molecules in autoimmune endocrine diseases with special reference to insulin-dependent diabetes mellitus. Autoimmunity 1989;4:191-218
7. Sandier S, Eizirik DL, Svensson C, Strandell E, Welsh M, Welsh N. Biochemical and molecular actions of interleukin-1 on pancreatic β cells. Autoimmunity 1991;10:241-53
8. Corbett JA, McDaniel ML. Perspectives in diabetes: does nitric oxide mediate autoimmune destruction of β-cells? Possible therapeutic interventions in IDDM. Diabetes 1992;41:897-903
9. Nerup J, Mandrup-Poulsen T, Helqvist S, Andersen HU, Pociot F, Reimers JI, et al. On the pathogenesis of IDDM. Diabetologia 1994;37 Suppl 2:S82-9
10. Scarborough DE. Cytokine modulation of pituitary hormone secretion. Ann NY Acad Sci 1990;594:169-87
11. Jones TH, Kennedy RL. Cytokines and hypothalamic-pituitary function. Cytokine 1993;5:531-8
12. Bernton EW, Beach JE, Holaday JW, Smallridge RC, Fein HG. Release of multiple hormones by a direct action of interleukin-1 on pituitary cells. Science 1987;238:519-21
13. Spangelo BL, Judd AM, Isakson PC, MacLeod RM. Interleukin-6 stimulates pituitary hormone release in vitro. Endocrinology 1989;125:575-7
14. Svenson M, Kayser L, Hansen MB, Rasmussen ÀK, Bendtzen K. Interleukin-1 receptors on human thyroid cells and on the rat thyroid cell line FRTL-5. Cytokine 1991;3:125-30
15. Pang X-P, Hershman JM, Chung M, Pekary AE. Characterization of tumor necrosis factor-α receptors in human and rat thyroid cells and regulation of the receptors by thyrotropin. Endocrinology 1989;125:1783-8
16. Nishikawa T, Yamashita S, Namba H, Usa T, Tominaga T, Kimura H, et al. Interferon-γ inhibition of human thyrotropin receptor gene expression. J Clin Endocrinol Metab 1993;77:1084-9
17. Wolf M, Hansen N, Greten H. Interleukin 1β. tumor necrosis factor-α and interleukin 6 decrease nuclear thyroid hormone receptor capacity in a liver cell line. Eur J Endocrinol 1994;131:307-12
18. Tominga T, Yamashita S, Nagayama Y, Morita S,Y okoyama N, Izumi M, et al. Interleukin 6 inhibits human thyroid peroxidase gene expression. Acta Endocrinol (Copenh) 1991;124:290-4
19. Bartalena L, Farsetti A, Fink IL, Robbins J. Effects of interleukin-6 on the expression of thyroid hormone-binding protein genes in cultured human hepatoblastoma-derived (Hep G2) cells. Mol Endocrinol 1992;6:935-42
20. Dubius J-M, Dayer J-M, Siegrist-Kaiser CA, Burger AG. Human recombinant interleukin-1β decreases plasma thyroid hormone and thyroid stimulating hormone levels in rats. Endocrinology 1988;123:2175-81
21. Van Der Poll T, Romijn JA, Wiersinga WM, Sauerwein HP. Tumor necrosis factor: a purative mediator of the sick euthyroid syndrome in man. J Clin Endocrinol Metab 1990;71:1567-72
22. Bartalena L, Grasso L, Brogioni S, Martino E. Interleukin 6 effects on the pituitary-thyroid axis in the rat. Eur J Endocrinol 1994;131:302-6
23. Hashimoto H, Igarashi N, Yachie A, Miyawaki T, Sato T. The relationship between serum levels of interleukin-6 and thyroid hormone in children with acute respiratory infection. J Clin Endocrinol Metab 1994;78:288-91
24. Docter R, Krenning EP, de Jong M, Hennemann G. The sick euthyroid syndrome: changes in thyroid hormone serum parameters and hormone metabolism. Clin Endocrinol 1993;39:499-518
25. Jones TH. Interleukin-6 an endocrine cytokine. Clin Endocrinol 1994;40:703-13
26. Grubeck-Loebenstein B, Buchan G, Chantry D, Kassal H, Londei M, Pinch K, et al. Analysis of intrathyroidal cytokine production in thyroid autoimmune disease: thyroid follicular cells produce interleukin-1α and interleukin-6. Clin Exp Immunol 1988;77:324-30
27. Watson PF, Pickerill AP, Davies R, Weetman AP. Analysis of cytokine gene expression in Graves' disease and multinodular goiter. J Clin Endocrinol Metab 1994;79:355-60
28. Enomoto T, Sugawa H, Inoue D, Miyamoto M, Kosugi S, Takahashi T, et al. Establishment of a human undifferentiated thyroid cancer cell line producing several growth factors and cytokines. Cancer 1990;65:1971-9
29. Weetman AP, Bright-Thomas R, Freeman M. Regulation of interleukin-6 release by human thyrocytes. J Endocrinol 1990;127:357-61
30. Weetman AP, Bennett GI, Wong WLT. Thyroid follicular cells produce interleukin-8. J Clin Endocrinol Metab 1992;75:328-30
31. Weetman AP, Tandon N, Morgan BP. Antithyroid drugs and release of inflammatory mediators by complement-attacked thyroid cells. Lancet 1992;340:633-6
32. Kennedy RL, Jones TH. Cytokines in endocrinology: their roles in health and in disease. J Endocrinol 1991;129:167-78
33. 125I organification and thyroid hormone release by interleukin-I, tumor necrosis factor-α, and Interferon-γ in human thyrocytes in suspension culture. J Clin Endocrinol Metab 1990;70:1735-43
34. Kung AWC, Lau KS. Interleukin-1β modulates thyrotropin-induced thyroglobulin mRNA transcription through 3′.5′-cyclic adenosine monophosphate. Endocrinology 1990;127:1369-74
35. Kayser L, Olsen BE, Hover PE, Quantitative cytochemical demonstration of intracellular thyroglobulin in cultured human thyrocytes. Effects of fixatives. TSH and interleukin 1β. Histochem J 1991;23:235-40
36. Yamashita S, Kimura H, Ashizawa K, Nagayama Y, Hirayu H, Izumi M, et al. Interleukin-1 inhibits thyrotrophin-induced human thyroglobulin gene expression. J Endocrinol 1989;122:177-83
37. Ashizawa K, Yamashita S, Tobinaga T,Nagayama Y, Kimura H, Hirayu H, et al. Inhibition of human thyroid peroxidase gene expression by interleukin 1. Acta Endocrinol (Copenh) 1989;121:465-9
38. Pang X-P, Hershman JM, Smith V, Pekary AE, Sugawara M. The mechanism of action of tumour necrosis factor-α and interleukin 1 on FRTL-5 rat thyroid cells. Acta Endocrinol (Copenh) 1990;123:203-10
39. Rasmussen ÅK, Kayser L, Beck K, Feldt-Rasmussen U, Perrild H, Bendtzen K. Differential effects of interleukin 1α and 1β on cultured human and rat thyroid epithelial cells. Acta Endocrinol (Copenh) 1990;122:520-6
40. Rasmussen ÅK, Bech K, Feldt-Rasmussen U, Poulsen S, Holten I, Ryberg M, et al. Interleukin-1 affects the function of cultured hyman thyroid cells. Allergy 1988;43:435-41
41. Kawabe Y, Eguchi K, Shimomura C, Mine M, Otsubo T, Ueki Y, et al. Interleukin-1 production and action in thyroid tissue. J Clin Endocrinol Metab 1989;68:1174-83
42. Zeki K, Azuma H, Suzuki H, Morimoto I, Eto S. Effects of interleukin 1 on growth and adenosine 3′.5′-monophosphate generation of the rat thyroid cell line, FRTL-5 cells. Acta Endocrinol (Copenh) 1991;124:60-6
43. Mine M, Tramontano D, Chin WW, Ingbar SH. Interleukin-1 stimulates thyroid cell growth and increases the concentration of the c-myc proto-oncogene mRNA in thyroid follicular cells in culture. Endocrinology 1987;120:1212-4
44. Zeki K, Nakano Y, Inokuchi N, Watanabe K, Morimoto I, Yamashita U, et al. Autocrine stimulation of interleukin-1 in the growth of human thyroid carcinoma cell line NIM 1. J Clin Endocrinol Metab 1993;76:127-33
45. Kimura H, Yamashita S, Namba H, Tominaga T, Tsuruta M, Yokoyama N, et al. Interleukin-1 inhibits human thyroid carcinoma cell growth. J Clin Endocrinol Metab 1992;75:596-602
46. Westermark K, Nilsson M, Karlsson FA. Effects of interleukin 1 alpha on porcine thyroid follicles in suspension culture. Acta Endocrinol (Copenh) 1990;122:505-12
47. McLachlan SM, Pegg CAS, Atherton MC, Middleton SL, Dickinson A, Clark F, et al. The thyroid microenvironment in autoimmune thyroid disease: Effects of TSH and lymphokines on thyroid lymphocytes and thyroid cells. Acta Endocrinol (Copenh) 1987;Suppl 281:125-32
48. Taverne J, Rayner DC, Van der Meide PH, Lydyard PM, Bidley SP, Cooke A. Cytotoxicity of tumour necrosis factor for thyroid epithelial cells and its regulatiom by interferon-γ. Eur J Immunol 1987;17:1855-8
49. Zakarija M, McKenzie JM. Influence of cytokines on growth and differentiated function for FRTL5 cells. Endocrinology 1989;125:1260-5
50. McLachlan SM, Taverne J, Atherton MC, Cooke A, Middleton S, Pegg CAS, et al. Cytokines, thyroid autoantibody synthesis and thyroid cell survival in culture. Clin Exp Immunol 1990;79:175-81
51. Huber GK, Davies TF. Human fetal thyroid cell growth in vitro: system characterization and cytokine inhibition. Endocrinology 1990;126:869-75
52. Asakawa H,Hanafusa T, Kobayashi T, Takai S-I, Kono N, Tarui S. Interferon-γ reduces the thyroid peroxidase content of cultured human thyrocytes and inhibits its increase induced by thyrotropin. J Clin Endocrinol Metab 1992;74:1331-5
53. Pang X-P, Park M, Hershman JM. Transforming growth factor-β blocks protein kinase-A-mediated iodide transport and protein kinase-C-mediated UNA synthesis in FRTL-5 rat thyroid cells. Endocrinology 1992;131:45-50
54. 125I incorporation and thyroid hormone release by human thryoid follicles in vitro. J Clin Endocrinol Metab 1993;77:1439-41
55. Tandon N, Morgan BP, Weetman AP. Expression and function of membrane attack complex inhibitory proteins on thyroid follicular cells. Immunology 1992;75:372-7
56. Grubeck-Loebenstein B, Londei M, Greenall C, Pirich K, Kassal H, Waldhäusl W, et al. Pathogenic relevance of HLA class II expressing thyroid follicular cells in non toxic goiter and in Graves' disease. J Clin Invest 1988;81:1608-14
57. Ebner SA, Stein ME, Minami M, Dorf ME, Stadecker MJ. Murine thyroid follicular epithelial cells can be induced to express class II (Ia) gene products but fail to present antigen in vitro. Cell Immunol 1987;104:154-68
58. Tang H, Mignon-Godefroy K, Meroni PL, Garotta G, Charriere J, Nicoletti F. The effects of a monoclonal antibody to interferon-γ on experimental autoimmune thyroiditis (EAT): prevention of disease and decrease of EAT-specific T cells. Eur J Immunol 1993;23:275-8
59. Kawakami Y, Kuzuya N, Watanabe T, Uchiyama Y, Yamashita K. Induction of experimental thyroiditis in mice by recombinant Interferon γ administration. Acta Endocrinol (Copenh) 1990;122:41-8
60. Nabozny GH, Kong Y-CM. Circumvention of the induction of resistance in murine experimental autoimmune thyroiditis by recombinant IL-1β. J Immunol 1992;149:1086-92
61. Wilson CA, Jacobs C, Baker P, Baskin DG, Dower S, Lernmark Å, et al. IL-1β modulation of spontaneous autoimmune diabetes and thyroiditis in the BB rat. J Immunol 1990;144:3784-8
62. Fentiman IS, Thomas BS, Balkwill FR, Rubens RD, Hayward JL. Primary hypothyroidism associated with interferon therapy of breast cancer. Lancet 1985;1:1166
63. Burman P, Tottermann TH, Oberg K, Karlsson FA. Thyroid autoimmunity in patients on long-term therapy with leukocyte derived interferon. J Clin Endocrinol Metab 1986;63:1086-90
64. Gisslinger H, Gilly B, Woloszczuk W, Mayr WR, Havelec L, Linkesch W, et al. Thyroid autoimmunity and hypothyroidism during long-term treatment with recombinant interferon-alpha. Clin Exp Immunol 1992;90:363-7
65. Van Liessum PA, De Mulder PMH, Mattijssen EJM, Corstens FHM, Wagener DJT. Hypothyroidism and goitre during interleukin-2 therapy without LAK cells. Lancet 1989;1:224
66. Hoekman K, Von Blomberg-Van Der Flier BME, Wagstaff J, Drexhage HA, Pinedo HM. Reversible thyroid dysfunction during treatment with GM-CSF. Lancet 1991;338:541-2
67. Miyakoshi H, Ohasawa K, Yokoyama H, Nagai Y, Ieki Y, Bando YI, et al. Exacerbation of hypothyroidism following tumour necrosis factor-alpha infusion. InternMed 1992;31:200-3
68. Scalzo S, Gengaro A, Boccoli G, Masciulli R, Giannella G, Salvo G, et al. Primary hypothyroidism associated with interleukin-2 and interferon alpha-2 therapy of melanoma and renal carcinoma. Eur J. Cancer 1990;26:1152-6
69. Hirooka Y, Ohtake K, Nogimori T, Mitsuma T. Impaired production of interleukin-2 (IL2) in patients with Graves' disease by newly developed IL2 radioimmunoassay. Exp Clin Endocrinol 1990;96:64-72
70. Loviselli A, Calia MA, Murenu S, Mossa P, Cambosu MA, Caradonna A. Circulating soluble IL-2 receptor levels are low in patients with hypothyroid autoimmune thyroiditis. Horm Metab Res 1994;26:548-51
71. Bartalena L, Grasso L, Brogioni S, Aghini-Lombardi F, Braverman LE, Martino E. Serum interleukin-6 in amiodarone-induced thyrotoxicosis. J Clin Endocrinol Metab 1994;78:423-7
72. Badenhoop K, Schwartz G, Schleusener H, Weetman AP, Recks S, Peters H, et al. Tumor necrosis factor β gene polymorphisms in Graves' disease. J Clin Endocrinol Metab 1992;74:287-91
73. Blakemore AIF, Watson PF, Weetman AP, Duff GW. Association of Graves' disease with an allele of the interleukin-1 receptor antagonist gene. J Clin Endocrinol Metab 1995;80:111-5
74. Pomposelli JJ, Enrique BS, Flores A, Bistrian BR. Role of biochemical mediators in clinical nutrition and surgical metabolism. J Parenteral Enteral Nut 1988;12:212-8
75. Berkenbosch F, de Goeij DEC, del Key A, Besedovsky HU. Neuroendocrine, sympathetic and metabolic responses induced by interleukin-1. Neuroendocrinology 1989;50:570-6
76. Besedovsky HO, del Rey A. Interleukin-1 and glucose homeostasis: an example of the biological relevance of immune-neuroendocrine interactions. Horm Res 1989;31:94-9
77. Bird TA, Davies A, Baldwin SA, Saklavala J. Interleukin 1 stimulates hexose transport in fibroblasts by increasing the expression of glucose transporters. J Biol Chem 1990;265:13578-83
78. Hernvann A, Aussel C, Cynober L, Moatti N, Ekindjian OG. IL-1β a strong mediator for glucose uptake by rheumatoid and non-rheumatoid cultured human synoviocytes. FEBS Lett 1992;303:77-80
79. Kohan DE, Schreiner GF. Interleukin 1 modulation of renal epithelial glucose and amino acid transport. Am J Physiol 1988:254:F879-86
80. Garcia-Welsh A, Schneiderman JS, Baly DL. Interleukin-1 stimulates glucose transport in rat adipose cells. Evidence for receptor discrimination between IL-1β and IL-1α. FEBS Lett 1990;269:421-4
81. Taylor DJ, Faragher EB, Evanson JM. Inflammatory cytokines stimulate glucose uptake and glycolysis but reduce glucose oxidation in human dermal fibroblasts in vitro. Circul Shock 1992;37:105-10
82. Del Rey A, Besedovsky H. Anti-diabetic effects of interleukin 1. Proc Natl Acad Sci USA 1989;86:5943-7
83. Endo Y, Suzuki R, Kumagai K. Interleukin 1-like factors can accumulate 5-hydroxytryptamine in the liver of mice and can induce hypoglycaemia. Biochim Biophys Acta 1985;840:37-42
84. Zamir O, Hasselgren P-O, Von Allmen D, Fischer JE. In vivo administration of interleukin-1α induces muscle proteolysis in normal and adrenalectomized rats. Metabolism 1993;42:204-8
85. Argilés JM, Lopez-Soriano F, Evans RD, Williamson DH. Interleukin-1 and lipid metabolism in the rat. Biochem J 1989;259:673-8
86. Feingold KR, Soued M, Staprans I, Gavin LA, Donahue ME, Huang B-J, et al. Effect of tumor necrosis factor (TNF) on lipid metabolism in the diabetic rat. Evidence that inhibition of adipose tissue lipoprotein lipase activity is not required for TNF-induced hyperlipidemia. J Clin Invest 1989;83:1116-21
87. Koivisto VA, Pelkonen R, Cantell K. Effect of interferon on glucose tolerance and insulin sensitivity. Diabetes 1989;38:641-7
88. Tredget EE, Yu YM, Zhong S, Burini R, Okusawa S, Gelfand JA, et al. Role of interleukin 1 and tumour necrosis factor on energy metabolism in rabbits. Am J Physiol 1988;255:E760-8
89. Lang CH, Dobrescu C, Bagby GJ. Tumor necrosis factor impairs insulin action on peripheral glucoase disposal and hepatic glucose output. Endocrinology 1992;130:43-52
90. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science 1993;259:87-91
91. Hofmann C, Lorenz K, Braithwaite SS, Colca JR, Palazuk BJ, Hotamisligil GS, et al. Altered gene expression for tumor necrosis factor-α and its receptors during drug and dietary modulation of insulin resistance. Endocrinology 1994;134:264-70
92. Hotamisligel GS, Spiegelman BM. Tumor necrosis factor α: a key component of the obesity-diabetes link. Diabetes 1994;43:1271-8
93. Cornell RP. Central interleukin 1-elicited hyperinsulinemia is mediated by prostaglandins but not autonomics. Am J Physiol 1989;257:R839-46
94. Purrello F, Buscema M. Effects of interleukin-1β on insulin secretion by pancreatic beta-cells. Diab Nutr Metab 1993;6:295-304
95. Palmer JP, Helqvist S, Spinas GA, Molvig J, Mandrup-Poulsen T, Andersen HU, et al. Interaction of β-cell activity and IL-1 concentration and exposure time in isolated rat islets of Langerhans. Diabetes 1989;38:1211-6
96. Spinas GA, Hansen BS, Linde S, Kastern W, Mølvig J, Mandrup-Poulsen T, et al. Inteleukin 1 dose-dependently affects the biosynthesis of (pro)insulin in isolated rat islets of Langerhans. Diabetologia 1987;30:474-80
97. Mandrup-Poulsen T, Bendtzen K, Nerup J, Dinarello CA, Svenson M, Nielsen JH. Affinity-purified human interleukin I is cytotoxic to isolated islets of Langerhans. Diabetologia 1986;29:63-7
98. Mandrup-Poulsen T, Egeberg J, Nerup J, Bendtzen, Nielsen JH, Dinarello CA. Ultrastructural studies of time-course and cellular specificity of interleukin 1 mediated islet cytotoxicity. Acta Path Microbiol Immunol Scand (C) 1987;95:55-63
99. Rabinovitch A, Suarez-Pinzon WL, Shi Y, Morgan AR, Bleackley RC. DNA fragmentation is an early event in cytokine-induced islet beta-cell destruction. Diabetologia 1994;37:733-8
100. Wogensen LD, Kolb-Bachofen V, Christiansen P, Dinarello CA, Mandrup-Poulsen T, Martin S, et al. Functional and morphological effects of interleukin-1β on the perfused rat pancreas. Diabetologia 1990;33:15-23
101. Cornell RP. Hyperinsulinemia elicited by interleukin-1 and nonlethal endotoxemia in rats, Circul Shock 1989;28:121-30
102. Vogel SN, Henrickson BE, Neta R. Roles of interleukin-1 and tumor necrosis factor in lipopolysaccharide-induced hypoglycemia. Infect Immun 1991;59:2494-8
103. Wogensen LD, Reimers J, Nerup J, Koib-Bachofen V, Kröncke K-D, Almdal T, et al. Repetitive in vivo treatment with human recombinant interleukin-1β modifies β-cell function in normal rats. Diabetologia 1992;35:331-9
104. Buschard K, Aaen K, Horn T, Damme JV, Bendtzen K. Interleukin 6: a functional and structural in vitro modulator of beta cells from islet of Langerhans. Autoimmunity 1990;5:185-94
105. Southern C, Schultser D, Green IC. Inhibition of insulin secretion from rat islets of Langerhans by interleukin-6. Biochem J 1990;272:243-5
106. Bendtzen K, Mandrup-Poulsen T, Nerup J, Nielsen JH, Dinarello CA, Svenson M. Cytotoxicity of human pl7 interleukin-1 for pancreatic islets of Langerhans. Science 1986;232:1545-7
107. Mandrup-Poulsen T, Bendtzen K, Dinarello CA, Nerup J. Human tumor necrosis factor potentiates human interleukin-1 mediated rat pancreatic beta-cell cytotoxicity. J Immunol 1987;139:4077-82
108. Rabinovitch A, Sumoski W, Rajotte RV, Warnock GL. Cytotoxic effects of cytokines on human pancreatic islet cells in monolayer culture. J Clin Endocrinol Metab 1990;71:152-6
109. Helqvist S, Zumsteg UW, Spinas GA, Palmer JP, Mandrup-Poulsen T, Egeberg J, et al. Repetitive exposure of pancreatic islets to interleukin-1β. An in vitro model of pre-diabetes? Autoimmunity 1991;10:311-8
110. Warren RS, Donner DB, Starnes HF, Brennan MF. Modulation of endogenous hormone action by recombinant human tumor necrosis factor. Proc Natl Acad Sci USA 1987;84:8619-22
111. Dayerle KL, Sims JE, Dower SK, Bothwell MA. Pattern of IL-1 receptor gene expression suggests role in noninflammatory processes. J Immunol 1992;149:1657-65
112. Hammonds P, Beggs M, Beresford G, Espinal J, Clarke J, Mertz RJ. Insulin-secreting β-cells possess specific receptors for interleukin-1β. FEBS Lett 1990;261:97-100
113. Eizirik DL, Björklund A, Welsh N. Interleukin-1-induced expression of nitric oxide synthase in insulin-producing cells is preceded by c-fos induction and depends on gene transcription and protein synthesis. FEBS Lett 1993;317:62-6
114. Bristulf J, Gatti S, Malinowsky D, Bjork, L, Sundgren AK, Bartfai T. Interleukin-1 stimulates the expression of type I and type II interleukin-1 receptors in the rat insulinoma cell line Rinm5F: sequencing a rat type II interleukin-1 receptor cDNA. Eur Cytokine Netw 1994;5:319-30
115. Jafarian-Tehrani M, Amrani A, Homo-Delarche F, Marquette C, Dardenne M, Haour F. Localization and characterization of interleukin-1 receptors in the islets of Langerhans from control and nonbese diabetic mice. Endocrinology 1995;136:609-13
116. Dayer-Metroz M-D, Willheim CB, Seckinger P, Dayer J-M. A natural interleukin 1 (IL-1) inhibitor counteracts the inhibitory effect of IL-1 on insulin production in cultured rat pancreatic islets. J Autoimmun 1989;2:163-71
117. Eizirik DL, Tracey DE, Bendtzen K, Sandier S. An interleukin-1 receptor antagonist protein products insulin-producing beta cells against suppressive effects of interleukin-1β. Diabetologia 1991;34:445-8
118. Zumsteg U, Reimers JI, Pociot F, March L, Helqvist S, Brendel M et al. Differential IL-1 receptor antagonism on rodent and human pancreatic islet β- and α cells. Diabetologia 1993;36:759-66
119. Mandrup-Poulsen T, Bendtzen K, Dinarello CA, Nerup J. Human tumor necrosis factor potentiates human interleukin-1 mediated rat pancreatic beta-cell cytotoxicity. J Immunol 1987;139:4077-82
120. Rabinovitch A, Sumoski W, Rajotte RV,Wamock GL. Cytotoxic effects of cytokines on human pancreatic islet cells in monolayer culture. J Clin Endocrinol Metab 1990;71:152-6
121. Margulis BA, Sandler S, Eizirik DL, Welsh M. Liposomal delivery of purified heat shock protein hsp70 into rat pancreatic islets as protection against interleukin 1β-induced impaired β-cell function. Diabetes 1991;40:1418-22
122. Cavallo MG, Baroni MG, Toto A, Gearing AJH, Forsey T, Andreani D, et al. Viral infection induces cytokine release by beta islet cells. Immunology 1992;75:664-8
123. Takane N, Yamada K, Otabe S, Inoue M, Nonaka K. Interleukin-1 induction of tumor necrosis factor-α mRNA and bioactive tumor necrosis factor-α in a pancreatic β-cell line by a mechanism requiring no de novo protein synthesis. Biochem Biophys Res Commun 1993;194:163-9
124. Foulis AK, Farquharson MA, Meager A. Immunoreactive α-interferon in insulin-secreting β cells in type 1 diabetes mellitus. Lancet 1987:1423-7
125. Somoza N, Vargas F, Roura-Mir C, Vives-Pi M, Fernández-Figueras MT, Ariza A, et al. Pancreas in recent onset insulin-dependent diabetes mellitus: Changes in HLA. adhesion molecules and autoantigens. restricted T cell receptor vβ usage and cytokine profile. J Immunol 1994;153:1360-77
126. Foulis AK, McGill M, Farquharson MA. Insulitis in type 1 (insulin-dependent) diabetes mellitus in man - macrophages, lymphocytes, and interferon-containing cells. J Pathol 1991;165:97-103
127. Campbell IL, Cutn A, Wilson A, Harrison LC. Evidence for IL-6 production by and effects on the pancreatic β-cell. 1989;143:1188-91
128. Harrison LC, Campbell IL, Allison J, Miller JFAP. MHC molecules and β-cell destruction. Immune and nonimmune mechanisms. Diabetes 1989;38:815-8
129. Campbell IL, Cutri A, Wilkinson D, Boyd AW, Harrison LC. Expression of intercellular adhesion molecule 1 is induced on isolated endocrine islet cells by cytokines but not by neovirus infection. Proc Natl Acad Sci USA 1989;89:4282-6
130. Vives M, Soldevila G, Alcalde L, Lorenzo C, Somoza N, Pujol-Borrell R. Adhesion molecules in human islet β-cells. De novo induction of ICAM-1 but not LFA-3. Diabetes 1991;40:1382-90
131. Prieto J, Kaaya EE, Juntti-Berggren L, Berggren P-O, Sandier S, Biberfeld P, et al. Induction of intercellular adhesion molecule-1 (CD54) on isolated mouse pancreatic β cells by inflammatory cytoines. Clin Immun Immunopathol 1992;65:247-53
132. Kjaer TW, Rygaard J, Bendtzen K, Josefsen K, Bock T, Buschard K. Interleukins increase surface ganglioside expression of pancreatic islet cells in vitro. APMIS 1992;100:509-14
133. Held W, MacDonald HR, Weissman IL, Hess MW, Mueller C. Genes encoding tumor necrosis factor α and granzyme A are expressed during development of autoimmune diabetes. Proc Natl Acad Sci USA 1990;87:2239-43
134. Jiang Z, Woda BA. Cytokine gene expression in the islets of the diabetic Biobreeding/Worcester rat. J Immunol 1991;146: 2990-4
135. Welsh M, Welsh N, Bendtzen K, Mares J, Strandell E, Öbert C, et al. Comparison of mRNA content of interleukin-1β and nitric oxide synthase in pancreatic islets isolated from female and male nonobese diabetic mice. Diabetologia 1995;38:153-60
136. Rabinovitch A, Saurez-Pinzon WL, Sorensen O, Bleackley RC, Power RF. IFNγ gene expression in pancreatic islet-infiltrating mononuclear cells correlates with autoimmune diabetes in NOD mice. J Immunol. In press
137. Toyoda H, Formby B, Magalong D, Redford A, Chan E, Takei S, et al. In situ islet cytokine gene expression during development of type I diabetes in the non-obese diabetic mouse. Immunol Lett 1994;39:283-8
138. Reimers JI, March L, Markholst H, Wogensen LD, Andersen HU, Mandrup-Poulsen T, et al. Interleukin-1β does not reduce the diabetes incidence in diabetes-prone BB rats. Autoimmunity 1994;17:105-18
139. Jacob CO, Aiso S, Michie SA, McDevitt HO, Acha-Orbea H. Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-α and interleukin 1. Proc Natl Acad Sci USA 1990;7:968-72
140. Kolb H, Zielasek J, Treichel U, Freytag G, Wrann M, Kiesel U. Recombinant interleukin 2 enhances spontaneous insulin-dependent diabetes in BB rats. Eur J Immunol 1986;16:209-12
141. Burstein D, Handler ES, Schindler J, Seals J, Mordes JP, Rossini AA. Effect of interleukin-2 on diabetes in the BB/Wor rat. Diabetes Res 1987;5:163-7
142. Satoh J, Seino H, Abo T, Tanaka S, Shintani S, Ohta S, et al. Recombinant human tumor necrosis factor α suppresses autoimmune diabetes in nonobese diabetic mice. J Clin Invest 1989;84:1345-8
143. Serreze DV, Hamaguchi K, Leiter EH. Immunostimulation circumvents diabetes in NOD/Lt mice. J Autoimmum 1989;2:759-76
144. Ewel C, Sobel DO, Zeligs B, Bellanti J, Poly I:C accelerates development of diabetes mellitus in diabetes-prone BB rat. Diabetes 1992;41:1016-21
145. Sobel DO, Newsome J, Ewel C, Bellanti JA, Abassi V, Creswell K, et al. Poly I:C induces development of diabetes mellitus in BB rat. Diabetes 1992;41:515-20
146. Sobel DO, Ewel CH, Zeligs B, Abassi V, Rossio J, Bellanti JA, Poly I:C induction of α-interferon in the diabetes-prone BB and normal Wistar rats. Diabetes 1994;43:518-22
147. Campbell IL, Oxbrow L, Harrison LC. Reduction in insulitis following administration of INF-γ and TNF-α in the NOD mouse. J Autoimmun 1991;4:249-62
148. Debray-Sachs M, Carnaud C, Boitard C, Cohen H, Gresser I, Bedossa P, et al. Prevention of diabetes in NOD mice treated with antibody to murine IFN-γ. J Autoimmum 1991;4:237-48
149. Nicoleetti F, Meroni PL, Landolfo S, Garigoto M, Guzzardi S, Barcellini W, et al. Prevention of diabetes in BB/Wor rats treated with antibodies to interferon-γ. Lancet 1990;336:319
150. Seino H, Takahashi K, Satoh J, Zhu XP, Sagara M, Masuda T, et al. Prevention of autoimmune diabetes with lymphotoxic in NOD mice. Diabetes 1993;42:398-404
151. Takahashi K, Satoh J, Scino H, Zhu XP, Sagara M, Masuda T, et al. Prevention of type 1 diabetes with lymphotoxin in BB rats. Clin Immunol Immunopathol 1993;3:318-23
152. Satoh J, Seino H, Shintani S, Tanaka S, Ohteki T, Masuda T, et al. Inhibition of type 1 diabetes in BB rats with recombinant human tumor necrosis factor-α. J Immunol 1990;145:1395-9
153. Tanaka S-I, Seino H, Satoh J, Fujii N, Rikiishi H, Zhu XP, et al. Increased in vivo production of tumor necrosis factor after development of diabetes in nontreated, long-term diabetic BB rats. Clin Immunol Immunopathol 1992;62:258-63
154. Rothe H, Fehsel K, Kolb H. Tumour necrosis factor alpha production is upregulated in diabetes prone BB rats. Diabetologia 1990;33:573-5
155. Rothe H, Schuller I, Richter G, Jongeneel CV, Kiesel U, Diamantstem T, et al. Abnormal TNF production in prediabetic BB rats is linked to defective CD45R expression. Immunology 1992;77:1-6
156. Prud'homme G, Fuks A, Colle E, Seemayer TA, Guttmann RD. Immune dysfunction in diabetes-prone BB rats. J Exp Med 1984;159:463-78
157. Serreze DV, Leiter EH. Defective activation of T suppressor cell function in nonobese diabetic mice. J Immunol 1988;140: 3801-7
158. Serreze DV, Hamaguchi K, Leiter EH. Immunostimulation circumvents diabetes in NOD/Lt mice. J Autoimmun 1989;2: 759-76
159. Dayer-Metroz MD, Duhamel D, Rufer N, Izui S, Carmichaels D, Wollheim CB, et al. IL-1 receptor antagonist delays spontaneous autoimmune diabetes in BB rats. Eur J Clin Inv 1992;22:A50
160. Lucic M, Stosic S. Interleukin 1 receptor antagonists prevent the induction of autoimmune diabetes. Autoimmunity 1993;14 Suppl 1:12
161. Nicoletti F, Di Marco R, Barcellini W, Magro G, Schorlemmer HU, Kurrle R, et al. Protection from experimental autoimmune diabetes in the non-obese diabetic mouse with soluble interleukin-1 receptor. Eur J Immunol 1994;24:1843-7
162. Sarvetnick N, Liggit D, Pitts SL, Hansen SE, Steward TA. Insulin-dependent diabetes mellitus induced in transgenic mice by ectopic expression of class II MHC and interferon-gamma. Cell 1988;52:773-82
163. Steward TA, Hultgren B, Huang X, Pitts-Meek S, Hully J, MacLachlan NJ. Induction of type I diabetes by interferon-α in transgenic mice. Science 1993;260:1942-6
164. Campbell IL, Iscaro A, Harrison LC. IFN-γ and tumour necrosis factor-α cytotoxicity to murine islets of Langerhans. J Immunol 1988;141:2325-9
165. Tovo PA, Cerutti F, Palomba E, Salomone C, Pugliese A. Evidence of circulating interferon-γ in newly diagnosed diabetic children. Acta Pædiatr Scand 1984;73:785-8
166. Hussain MJ, Peakman M, Leslie RDG, Viberti GC, Watkins PJ, Vergani D. Circulating levels of interleukin-1α (IL-1α), tumour necrosis factor-α (TNF-α) and interferon-gamma (IFN-gamma) are high in newly-diagnosed type 1 diabetics. Diabetes 1991;40 Suppl 1:587
167. Espersen GT, Mathiasen O, Grunnet N, Jensen S, Ditzel J. Cytokine plasma levels and lymphocyte subsets in patients with newly diagnosed insulin-dependent (type 1) diabetes mellitus before and following insulin treatment. APMIS 1993;101: 703-6
168. Ciampolillo A, Guastamacchia E, Caragiulo L, Lollino G, Robertis OD, Lattanzi V, et al. In vitro secretion of interleukin-1β and interferon-gamma by peripheral blood lymphomononuclear cells in diabetic patients. Diab Res Clin Pract 1993;21:87-93
169. Pociot F, Mølvig J, Wogensen L, Worsaae H, Nerup J. A Taql polymorphism in the human interleukin-1β (IL-1β) gene correlates with IL-1β secretion in vivo. Eur J Clin Invest 1992;22:396-402
170. Pociot F, Molvig J, Wogensen L, Worsaae H, Dalbøge H, Back L, et al. A tumour necrosis factor beta gene polymorphism in relation to monokine secretion and insulin-dependent diabetes mellitus. Scand J Immunol 1991;33:37-49
171. Pociot F, Briant L, Jongeneel CV, Worsaae H, Molvig J, Abbal M, et al. Association of tumour necrosis factor (TNF) and class II MHC alleles with the secretion of TNFα and TNFβ by human mononuclear cells: A possible link to insulin-dependent diabetes mellitus. Eur J Immunol 1993;23:224-31
172. Mandrup-Poulsen T, Pociot F, Mølvig J, Shapiro L, Nilsson P, Emdal T, et al. Monokine antagonism is reduced in patients with insulin-dependent diabetes mellitus. Diabetes 1994;43:1242-7
173. Bergholdt R, Karlsen AE, Johannesen J, Hansen PM, Dinarello CA, Nerup J,
174. Ghosh S, Palmer SM, Rodrigues NR, Cordell HJ, Hearne CM, Cornall RJ, et al. Polygenic control of autoimmune diabetes in nonobese diabetic mice. Nature Genet 1993;4:404-9